Your browser doesn't support javascript.
loading
Case-crossover study design in pharmacoepidemiology: systematic review and recommendations.
Consiglio, Giulia P; Burden, Andrea M; Maclure, Malcolm; McCarthy, Lisa; Cadarette, Suzanne M.
  • Consiglio GP; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Pharmacoepidemiol Drug Saf ; 22(11): 1146-53, 2013 Nov.
Article en En | MEDLINE | ID: mdl-24030723
ABSTRACT

PURPOSE:

The purpose of this study is to systematically identify and review articles that use the case-crossover study design in the area of pharmacoepidemiology.

METHODS:

A systematic search of MEDLINE® (Ovid Technologies, New York City, NY, USA), EMBASE® (Elsevier Inc., Philadelphia, PA, USA), and Web of Science® (Thomson Reuters, New York City, NY, USA) was completed to identify all English language articles that applied the case-crossover study design in the area of pharmacoepidemiology. The number of reviews, methodological contributions, and empirical pharmacoepidemiologic applications were summarized by publication year. Empirical applications were retrieved, and methodological details (outcome, exposure, exposure windows, sensitivity analysis, statistical reporting) were tabulated and compared to methodological recommendations based on exposure characteristics, exposure windows, and discordant pairs data display.

RESULTS:

Of 836 unique articles identified, 99 pharmacoepidemiologic studies were eligible 20 methodological contributions, 9 review papers, and 70 empirical applications. Only three empirical applications in the area of pharmacoepidemiology were published before 2000. Since 2000, the number of empirical pharmacoepidemiologic applications published annually has generally increased over time, to before a high of 15 published in 2011. The design was mainly applied to examine drug safety (96%), and most applications investigated psychotropic (24%) and analgesic (17%) exposure drug classes; and considered hospitalization (23%) and cardiovascular/cerebrovascular (21%) events. Only 31% of applications displayed sufficient data to enable readers to confirm odds ratios presented.

CONCLUSIONS:

Use of the case-crossover design in pharmacoepidemiology has increased rapidly in the last decade. As the application of the case-crossover design continues to increase, it is important to develop standards of practice, especially for display of data.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proyectos de Investigación / Diseño de Investigaciones Epidemiológicas / Farmacoepidemiología Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proyectos de Investigación / Diseño de Investigaciones Epidemiológicas / Farmacoepidemiología Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article